Photo CHUB
FRNLEN

>>Aperçu des publications scientifiques du Prof. Anne-Sophie HAMBYE

Anne-Sophie HAMBYE

1: Weyts K, Spinato L, Bisschop P, Jaudet C, Hamb e AS. Dynamic Scintigraphy With SPECT-CT of Postoperative Salivary Leak. Clin Nucl Med. 2016 May;41(5):e257-8. doi: 10.1097/RLU.0000000000001120.
>PubMed

2: Safouris A, Hambye AS, Sculier C, Papageorgiou SG, Vasdekis SN, Gazagnes MD, Tsivgoulis G. Chronic brain hypoperfusion due to multi-vessel extracranial atherosclerotic disease: a potentially reversible cause of cognitive impairment. J Alzheimers Dis. 2015;43(1):23-7. doi: 10.3233/JAD-141203.
>PubMed

3: Tondeur M, Hambye AS, Sand A, Ham H. Educational impact of discussing results among nuclear medicine physicians participating in interobserver reproducibility studies: our experience with I-123 FP-CIT SPECT. Nucl Med Commun. 2011 May;32(5):410-5. doi: 10.1097/MNM.0b013e32834508ee.
>PubMed

4: Tondeur MC, Hambye AS, Dethy S, Ham HR. Interobserver reproducibility of the interpretation of I-123 FP-CIT single-photon emission computed tomography. Nucl Med Commun. 2010 Aug;31(8):717-25.
>PubMed

5: Hamb e AS, Vervaet A, Dethy S. FP-CIT SPECT in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up. Nucl Med Commun. 2010 Jun;31(6):583-9.
>PubMed

6: Hamb e AS, Delsarte P, Vervaet AM. Influence of the different biokinetics of sestamibi and tetrofosmin on the interpretation of myocardial perfusion imaging in daily practice. Nucl Med Commun. 2007 May;28(5):383-90.
>PubMed

7: Hambye AS, Vervaet A, Dobbeleir A. Variability of left ventricular ejection fraction and volumes with quantitative gated SPECT: influence of algorithm, pixel size and reconstruction parameters in small and normal-sized hearts. Eur J Nucl Med Mol Imaging. 2004 Dec;31(12):1606-13. Epub 2004 Jul 31.
>PubMed

8: Hambye AS, Vervaet AM, Dobbeleir AA. Head-to-head comparison of uncorrected and scatter corrected, summed and end diastolic myocardial perfusion SPECT in coronary artery disease. Nucl Med Commun. 2004 Apr;25(4):347-53.
>PubMed

9: Hamb e AS, Vervaet A, Dobbeleir A, Dendale P, Franken P. Prediction of functional outcome by quantification of sestamibi and BMIPP after acute myocardial infarction. Eur J Nucl Med. 2000 Oct;27(10):1494-500.
>PubMed

10: Hambye AS, Dobbeleir AA, Vervaet AM, Van den Heuvel PA, Franken PR. BMIPP imaging to improve the value of sestamibi scintigraphy for predicting functional outcome in severe chronic ischemic left ventricular dysfunction. J Nucl Med. 1999 Sep;40(9):1468-76.
>PubMed

11: Franken PR, Hamb e AS, De Geeter FW. BMIPP imaging to assess functional outcome in patients with acute and chronic left ventricular dysfunction. Int J Card Imaging. 1999 Feb;15(1):27-34. Review.
>PubMed

12: Hambye AS, Vervaet A, Dobbeleir A. Quantification of 99Tcm-sestamibi and 123I-BMIPP uptake for predicting functional outcome in chronically ischaemic dysfunctional myocardium. Nucl Med Commun. 1999 Aug;20(8):737-45.
>PubMed

13: Dobbeleir AA, Hamb e AS, Franken PR. Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: consequences for imaging with 123I-labelled compounds in clinical practice. Eur J Nucl Med. 1999 Jun;26(6):655-8.
>PubMed

14: Mesotten L, Maes A, Hambye AS, Everaert H, Van den Maegdenbergh V, Franken P, Mortelmans L. Nuclear cardiology, Part IV: Viability. J Nucl Med Technol. 1999 Jun;27(2):93-102; quiz 104-5. Review.
>PubMed

15: Dobbeleir AA, Hambye AS, Franken PR. Influence of methodology on the presence and extent of mismatching between 99mTc-MIBI and 123I-BMIPP in myocardial viability studies. J Nucl Med. 1999 May;40(5):707-14.
>PubMed

16: Hamb e AS, Vaerenberg MM, Dobbeleir AA, Van den Heuvel PA, Franken PR. Abnormal BMIPP uptake in chronically dysfunctional myocardial segments: correlation with contractile response to low-dose dobutamine. J Nucl Med. 1998 Nov;39(11):1845-50.
>PubMed

17: Everaert H, Maes A, Hambye AS, Mesotten L, Mortelmans L, Franken PR. Nuclear cardiology, Part III: Scintigraphic evaluation of cardiac perfusion. J Nucl Med Technol. 1998 Sep;26(3):164-9; quiz 172-3.
>PubMed

18: Hamb e AS, Everaert H, Maes A, Mesotten L, Vandevivere J, Mortelmans L, Franken PR. Nuclear cardiology, Part II: Scintigraphic evaluation of cardiac function. J Nucl Med Technol. 1998 Jun;26(2):72-9; quiz 84, 86. Review.
>PubMed

19: Mesotten L, Maes A, Hamb e AS, Everaert H, Van den Maegdenbergh V, Franken P, Mortelmans L. Nuclear cardiology, Part I: Anatomy and function of the normal heart. J Nucl Med Technol. 1998 Mar;26(1):4-8. Review.
>PubMed

20: Hamb e AS, Dobbeleir A, Franken PR. SPET-generated colour-coded polar maps to quantify 99Tcm-MIBI and 123I-BMIPP uptake in chronically dysfunctional myocardium: comparison with coronary anatomy and wall motion. Nucl Med Commun. 1997 Dec;18(12):1135-47.
>PubMed

21: Hamb e AS, Verbeke KA, Vandermeiren RP, Joosens EJ, Verbruggen AM, De Roo MJ. Comparison of modified technetium-99m albumin and technetium-99m red blood cells for equilibrium ventriculography. J Nucl Med. 1997 Oct;38(10):1521-8.
>PubMed

22: Hamb e AS, Dobbeleir A, Vervaet A, Chi-Chou H. Can we rely on 99Tcm-sestamibi gated tomographic myocardial perfusion imaging to quantify left ventricular function? A comparative study with classical isotopic techniques for the measurement of ejection fraction. Nucl Med Commun. 1997 Aug;18(8):751-60.
>PubMed

23: Hamb e AS, Dobbeleir A, Derveaux M, Vandevivere J, van den Heuvel P. Determination of systolic thickening index with gated Tc-99m sestamibi SPECT. A new parameter of myocardial viability? Clin Nucl Med. 1997 Mar;22(3):172-5.
>PubMed

24: Hamb e AS, Vervaet A, Lieber S, Ranquin R. Diagnostic value and incremental contribution of bicycle exercise, first-pass radionuclide angiography, and 99mTc-labeled sestamibi single-photon emission computed tomography in the identification of coronary artery disease in patients without infarction. J Nucl Cardiol. 1996 Nov-Dec;3(6 Pt 1):464-74.
>PubMed

25: Hambye AS, Dobbeleir A, Stulens E, Vervaet A, Vandevivere J, Franken PR. 240 degrees: why not? Nucl Med Commun. 1996 Jul;17(7):583-90.
>PubMed

26: Hambye AS, Van Den Branden F, Vandevivere J. Diagnostic value of Tc-99m sestamibi gated SPECT to assess viability in a patient after acute myocardial infarction. Clin Nucl Med. 1996 Jan;21(1):19-23.
>PubMed

27: Hambye AS, Vandermeiren R, Vervaet A, Vandevivere J. Failure to label red blood cells adequately in daily practice using an in vivo method: methodological and clinical considerations. Eur J Nucl Med. 1995 Jan;22(1):61-7.
>PubMed

28: Hambye AS, Hermans J, Wadeleux P, Bezy F, Bodart F, Beauduin M. [Determination of thyroid peroxidase antibodies in common thyroid pathology. Methodological and clinical approach]. Ann Endocrinol (Paris). 1993;54(3):181-9. French.
>PubMed

29: Hambye AS, Merlo P, Hermans J, Bodart F, Beauduin M, Gilbeau JP. Kidney depth measured by using 99Tcm-DMSA. Comparison with CAT scan: review of 50 measurements. Nucl Med Commun. 1992 Jul;13(7):488-93.
>PubMed

!Données extraites de PubMed et filtrées pour limiter les risques d'homonymie. Vous pouvez supprimer le filtre "Brugmann" afin d'élargir les résultats.

>>Consulter la fiche d'identitÚ du Prof. Anne-Sophie HAMBYE.